Publication | Closed Access

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer

Breast OncologyOncologyMedicineLocally AdvancedClinical TrialsCapecitabine Versus PlaceboBreast CancerCancer TreatmentPharmacologyMolecular OncologyPhase Iii Randomized